Diabetic dyslipidemia is characterised by high plasma triglycerides (TG), low highdensity lipoprotein cholesterol (HDL-C) and increased small dense low-density lipoprotein cholesterol (LDL-C) particles. Obesity, poor glycaemic control, high fat low fibre diet, and smoking increase the risk of dyslipidemia in type 2 diabetes. Recent published reports have suggested beneficial effect of nutraceut...

OBJECTIVE The polymorphisms/mutations of genes encoding proteins and enzymes involved in lipoprotein metabolism play important roles in the development of diabetic dyslipidemia. The aim of our study was to investigate the effects of LPL (rs320), LIPC (rs2070895), SCARB1 (rs5888), LCAT (rs2292318), CETP (rs708272), ADIPOQ (rs1501299), RETN (rs3745367), PON1 (rs662), and MNSOD (rs4880) gene polym...

BACKGROUND Despite the importance of identifying and screening dyslipidemia to prevent coronary artery diseases CAD(Coronary Artery Disease), little information is available on dyslipidemia in our large area. So the present study aimed to assess the management status of lipid abnormalities and its association with other CAD risk factors in an urban population of southeast of Iran. METHODS Thi...

OBJECTIVE To examine cardiovascular disease risk factors and risk clusters in Swedish persons with traumatic wheelchair-dependent paraplegia. DESIGN Prospective examination. SUBJECTS A total of 135 individuals aged 18-79 years with chronic (>or= 1 year) post-traumatic paraplegia. METHODS Cardiovascular disease risk factors; dyslipidemia, impaired fasting glucose, hypertension, overweight,...

Background Dyslipidemia is a major risk for cardiovascular diseases. The aim of this study is to review the effects of nutraceuticals to modify lipid disorders in children. Materials and Methods The literature research was conducted in EMBASE, Medline, PubMed, Scopus, ISI Web of Science, and Cochrane library from 2002 until January 2015. The following keywords were used: dyslipidemia, hyperlipi...

Aim: To determine the frequency of dyslipidemia in patients of liver cirrhosis and the mean lipid profile in patients of liver cirrhosis. Methods: This cross sectional study was conducted at Department of Medicine, BVH, Bahawalpur from January 2013 to June 2013. In this study, 171 patients with cirrhosis of liver were included. Results and Conclusion: Out of 171 cirrhotic patients, dyslipidemia...

The “2016 Chinese guideline for the management of dyslipidemia in adults” (the new Guide for short) released by Chinese Journal of Cardiology is based on the 2007 “Guide for Dyslipidemia Prevention in Chinese Adults” (the 2007 Hyperlipidemia Guide for short) and is the result of a year's effort and work by a team of specialists. The public release of the 2007 Hyperlipidemia Guide has had a posi...

Dyslipidemia is a well-established risk factor for atherosclerosis. Treating dyslipidemia in elderly patients requires specific knowledge and understanding of common dyslipidemias and the relative safety of various pharmacologic agents in the presence of possible multiple comorbidities. Lifestyle modification remains the first step in the treatment of dyslipidemia; however, it can be difficult ...

BACKGROUND Diabetes mellitus is a group of metabolic disorders that are caused by deficiency in insulin secretion or the decreased ability of insulin to act effectively on target tissues, particularly muscle, liver, and fat. As a result of insulin resistance in the target tissues, particularly in the adipocytes, free fatty acid flux is increased, leading to increased lipid synthesis in hepatocy...

Dyslipidemia has significantly contributed to the increase of death and morbidity rates related to cardiovascular diseases. Clinical nutrition service provided by dietitians has been reported to have a positive effect on relief of medical symptoms or reducing the further medical costs. However, there is a lack of researches to identify key competencies and job standard for clinical dietitians t...